Enzo Biochem (ENZ)
Q1 2014 Earnings Call
December 11, 2013 8:30 am ET
Barry W. Weiner - Co Founder, President, Chief Financial Officer, Principal Accounting Officer, Treasurer and Director
David C. Goldberg - Vice...
Enzo Biochem Inc. (NYSE:ENZ) today reported results for the fiscal first
quarter ended October 31, 2013. Highlights include:
Net loss for the quarter was reduced by over $0.9 million from a year
ago and $0.3 million...
Biochem, Inc. (NYSE:ENZ), will hold a conference call to discuss
fiscal 2014 first quarter results, Wednesday, December 11, 2013, at 8:30
To listen to the conference call dial 1-888-459-5609....
Enzo Biochem (NYSE: ENZ) reported today that a Federal Court Judge in New
Haven, CT, has upheld the jury verdict issued in November 2012 which awarded
Enzo $48.6 million in direct infringement damages as a result of Applera
Corp., now Life...
Enzo Biochem (NYSE: ENZ) announced today that it has arranged an $8 million senior secured revolving line of credit that may be increased to $12 million with Healthcare Finance Group, LLC (HFG), of New York, New York, that may be utilized for...
The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article.